EORTC 10968 : a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer (European Organization for Research and Treatment of Cancer)
Nom du journal : Ann Oncol
Année : 2002
Volume : 13
Page de départ : 910
Page de fin : 918